##GS140127_01 ref_correl: 0.945 (median: 0.971)
##GS140127_01 cnvs: 174 (median: 43)
##GS140127_01 qc_errors:
##GS140549_01 ref_correl: 0.962 (median: 0.971)
##GS140549_01 cnvs: 167 (median: 43)
##GS140549_01 qc_errors:
##GS140550_01 ref_correl: 0.959 (median: 0.971)
##GS140550_01 cnvs: 131 (median: 43)
##GS140550_01 qc_errors:
#chr	start	end	sample	size	region_count	region_copy_numbers	region_zscores	region_cnv_af	region_coordinates	overlaps_cnp_region	genes	dosage_sensitive_disease_genes	omim
chr1	6535512	6535592	multi	80	1	3	4.32	0.046	chr1:6535512-6535592		PLEKHG5		611101_[PLEKHG5_(confirmed)_Spinal_muscular_atrophy,distal,autosomal_recessive,4,611067|Charcot-Marie-Tooth_disease,recessive_intermediate_C,615376]
chr1	12066585	12066760	multi	175	1	1	-3.81	0.026	chr1:12066585-12066760		MFN2		608507_[MFN2_(confirmed)_Charcot-Marie-Tooth_disease,axonal,type_2A2A,609260|Hereditary_motor_and_sensory_neuropathy_VIA,601152|Charcot-Marie-Tooth_disease,axonal,type_2A2B,617087]
chr1	22190583	22191576	multi	993	2	1,1	-2.48,-3.59	0.039,0.026	chr1:22190583-22190716,chr1:22191326-22191576		HSPG2	HSPG2	142461_[HSPG2_(confirmed)_Schwartz-Jampel_syndrome,type_1,255800|Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	24122631	24122765	multi	134	1	1	-4.23	0.046	chr1:24122631-24122765		GALE		606953_[GALE_(confirmed)_Galactose_epimerase_deficiency,230350]
chr1	24172554	24172673	multi	119	1	3	3.68	0.020	chr1:24172554-24172673		FUCA1		612280_[FUCA1_(confirmed)_Fucosidosis,230000]
chr1	43205502	43205935	multi	433	1	1	-4.42	0.072	chr1:43205502-43205935		CLDN19		610036_[CLDN19_(confirmed)_Hypomagnesemia_5,renal,with_ocular_involvement,248190]
chr1	67518444	67518550	multi	106	1	3	4.03	0.026	chr1:67518444-67518550		SLC35D1		610804_[SLC35D1_(confirmed)_Schneckenbecken_dysplasia,269250]
chr1	92951561	92951638	multi	77	1	4	4.71	0.046	chr1:92951561-92951638		GFI1		600871_[GFI1_(confirmed)_Neutropenia,severe_congenital_2,autosomal_dominant,613107|Neutropenia,nonimmune_chronic_idiopathic,of_adults,607847]
chr1	109756505	109756760	multi	255	1	3	4.7	0.065	chr1:109756505-109756760		SARS		607529_[SARS_(provisional)_Neurodevelopmental_disorder_with_microcephaly,ataxia,and_seizures,617709]
chr1	161136171	161136472	multi	301	1	3	3.99	0.085	chr1:161136171-161136472		PPOX		600923_[PPOX_(provisional)_Porphyria_variegata,176200]
chr1	161179891	161180189	multi	298	2	3,3	4.17,2.62	0.026,0.020	chr1:161179891-161179988,chr1:161180084-161180189		NDUFS2		602985_[NDUFS2_(provisional)_Mitochondrial_complex_I_deficiency,252010]
chr1	201022327	201023699	multi	1372	3	1,1,1	-3,-3.75,-2.52	0.013,0.013,0.052	chr1:201022327-201022412,chr1:201022577-201022725,chr1:201023623-201023699		CACNA1S		114208_[CACNA1S_(confirmed)_Hypokalemic_periodic_paralysis,type_1,170400|Malignant_hyperthermia_susceptibility_5,601887|Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	235530718	235530877	multi	159	1	3	5.08	0.059	chr1:235530718-235530877		TBCE	TBCE	604934_[TBCE_(confirmed)_Kenny-Caffey_syndrome,type_1,244460|Hypoparathyroidism-retardation-dysmorphism_syndrome,241410|Encephalopathy,progressive,with_amyotrophy_and_optic_atrophy,617207]
chr1	247579448	247579505	multi	57	1	4	5	0.020	chr1:247579448-247579505		NLRP3		606416_[NLRP3_(confirmed)_Familial_cold-induced_inflammatory_syndrome_1,120100|Muckle-Wells_syndrome,191900|CINCA_syndrome,607115|Deafness,autosomal_dominant_34,with_or_without_inflammation,617772]
chr2	27545305	27545979	multi	674	2	3,3	3.41,5.13	0.065,0.065	chr2:27545305-27545399,chr2:27545909-27545979		MPV17		137960_[MPV17_(provisional)_Mitochondrial_DNA_depletion_syndrome_6_(hepatocerebral_type),256810]
chr2	44139561	44139707	multi	146	1	3	4.12	0.137	chr2:44139561-44139707		LRPPRC		607544_[LRPPRC_(confirmed)_Leigh_syndrome,French-Canadian_type,220111]
chr2	109367710	109368169	multi	459	2	3,3	4.71,3.86	0.013,0.020	chr2:109367710-109367911,chr2:109367974-109368169		RANBP2		601181_[RANBP2_(provisional)_Encephalopathy,acute,infection-induced,3,susceptibility_to,608033]
chr2	152553141	152553259	multi	118	1	3	3.83	0.092	chr2:152553141-152553259		NEB		161650_[NEB_(confirmed)_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	170151100	170151230	multi	130	1	3	3.65	0.020	chr2:170151100-170151230		LRP2	LRP2	600073_[LRP2_(confirmed)_Donnai-Barrow_syndrome,222448]
chr2	179558326	179558426	multi	100	1	3	4.57	0.039	chr2:179558326-179558426		TTN, TTN-AS1		188840_[TTN_(confirmed)_Cardiomyopathy,familial_hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial_muscular_dystrophy,tardive,600334|Muscular_dystrophy,limb-girdle,type_2J,608807|Myopathy,proximal,with_early_respiratory_muscle_involvement,603689|Salih_myopathy,611705]
chr2	190444529	190444616	multi	87	1	3	4.7	0.026	chr2:190444529-190444616		SLC40A1		604653_[SLC40A1_(confirmed)_Hemochromatosis,type_4,606069]
chr2	191849026	191850396	multi	1370	2	3,3	2.51,3.6	0.020,0.007	chr2:191849026-191849129,chr2:191850335-191850396		STAT1		600555_[STAT1_(provisional)_Immunodeficiency_31A,mycobacteriosis,autosomal_dominant,614892|Immunodeficiency_31B,mycobacterial_and_viral_infections,autosomal_recessive,613796|Immunodeficiency_31C,autosomal_dominant,614162]
chr2	198363389	198363584	multi	195	1	3	3.57	0.046	chr2:198363389-198363584		HSPD1		118190_[HSPD1_(confirmed)_Spastic_paraplegia_13,autosomal_dominant,605280|Leukodystrophy,hypomyelinating,4,612233]
chr2	207024055	207024253	multi	198	1	3	4.15	0.033	chr2:207024055-207024253		NDUFS1		157655_[NDUFS1_(provisional)_Mitochondrial_complex_I_deficiency,252010]
chr2	227898116	227906981	multi	8865	2	3,3	3.87,3.67	0.105,0.098	chr2:227898116-227898207,chr2:227906854-227906981		COL4A4		120131_[COL4A4_(confirmed)_Alport_syndrome,autosomal_recessive,203780|Hematuria,familial_benign]
chr2	240098099	240098269	multi	170	1	1	-3.7	0.013	chr2:240098099-240098269		HDAC4	HDAC4	
chr3	4508650	4508976	multi	326	1	1	-3.88	0.033	chr3:4508650-4508976		SUMF1	SUMF1	607939_[SUMF1_(provisional)_Multiple_sulfatase_deficiency,272200]
chr3	4536105	4536200	multi	95	1	3	6.51	0.020	chr3:4536105-4536200		ITPR1	ITPR1	147265_[ITPR1_(confirmed)_Spinocerebellar_ataxia_15,606658|Spinocerebellar_ataxia_29,congenital_nonprogressive,117360|Gillespie_syndrome,206700]
chr3	14219956	14220182	multi	226	1	1	-4.03	0.026	chr3:14219956-14220182		LSM3, XPC		613208_[XPC_(confirmed)_Xeroderma_pigmentosum,group_C,278720]
chr3	30715587	30715748	multi	161	1	3	3.74	0.007	chr3:30715587-30715748		TGFBR2	TGFBR2	190182_[TGFBR2_(confirmed)_Colorectal_cancer,hereditary_nonpolyposis,type_6,614331|Esophageal_cancer,somatic,133239|Loeys-Dietz_syndrome_2,610168]
chr3	33093240	33093300	multi	60	1	3	5.47	0.039	chr3:33093240-33093300		GLB1		611458_[GLB1_(confirmed)_GM1-gangliosidosis,type_I,230500|GM1-gangliosidosis,type_II,230600|GM1-gangliosidosis,type_III,230650|Mucopolysaccharidosis_type_IVB_(Morquio),253010]
chr3	46620575	46620866	multi	291	2	3,3	6.52,3.29	0.020,0.020	chr3:46620575-46620647,chr3:46620712-46620866		LRRC2, TDGF1	TDGF1	187395_[TDGF1_(confirmed)_Forebrain_defects]
chr3	48619129	48619202	multi	73	1	3	5.25	0.026	chr3:48619129-48619202		COL7A1		120120_[COL7A1_(confirmed)_Epidermolysis_bullosa_dystrophica,AD,131750|Epidermolysis_bullosa_dystrophica,AR,226600|Epidermolysis_bullosa,pretibial,131850|EBD,Bart_type,132000|EBD,localisata_variant|Transient_bullous_of_the_newborn,131705|Epidermolysis_bullosa_pruriginosa,604129|Toenail_dystrophy,isolated,607523|EBD_inversa,226600]
chr3	48626293	48626438	multi	145	1	1	-3.72	0.013	chr3:48626293-48626438		COL7A1		120120_[COL7A1_(confirmed)_Epidermolysis_bullosa_dystrophica,AD,131750|Epidermolysis_bullosa_dystrophica,AR,226600|Epidermolysis_bullosa,pretibial,131850|EBD,Bart_type,132000|EBD,localisata_variant|Transient_bullous_of_the_newborn,131705|Epidermolysis_bullosa_pruriginosa,604129|Toenail_dystrophy,isolated,607523|EBD_inversa,226600]
chr3	128621386	128621481	multi	95	1	1	-3.65	0.026	chr3:128621386-128621481		ACAD9		611103_[ACAD9_(confirmed)_Mitochondrial_complex_I_deficiency_due_to_ACAD9_deficiency,611126]
chr3	139062851	139063050	multi	199	1	4	6.69	0.105	chr3:139062851-139063050		MRPS22		605810_[MRPS22_(confirmed)_Combined_oxidative_phosphorylation_deficiency_5,611719]
chr3	193335563	193335636	multi	73	1	3	4	0.013	chr3:193335563-193335636		OPA1	OPA1	605290_[OPA1_(confirmed)_Optic_atrophy_1,165500|Glaucoma,normal_tension,susceptibility_to,606657|Optic_atrophy_plus_syndrome,125250|Behr_syndrome,210000|Mitochondrial_DNA_depletion_syndrome_14_(encephalocardiomyopathic_type),616896]
chr3	197024047	197024116	multi	69	1	4	6.26	0.046	chr3:197024047-197024116		DLG1	DLG1	
chr3	197404341	197404422	multi	81	1	3	7.26	0.033	chr3:197404341-197404422		RUBCN		613516_[KIAA0226_(provisional)_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr3	197410168	197410320	multi	152	1	3	4.56	0.059	chr3:197410168-197410320		RUBCN		613516_[KIAA0226_(provisional)_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr4	1900938	1901132	multi	194	1	3	4.02	0.059	chr4:1900938-1901132		NSD2	NSD2	
chr4	15471479	15471691	multi	212	1	3	3.61	0.033	chr4:15471479-15471691		CC2D2A	CC2D2A	612013_[CC2D2A_(confirmed)_Joubert_syndrome_9,612285|Meckel_syndrome_6,612284|COACH_syndrome,216360]
chr4	17492275	17492378	multi	103	1	3	4.34	0.059	chr4:17492275-17492378		QDPR		612676_[QDPR_(confirmed)_Hyperphenylalaninemia,BH4-deficient,C,261630]
chr4	79203964	79204131	multi	167	1	3	4.8	0.098	chr4:79203964-79204131		FRAS1		607830_[FRAS1_(confirmed)_Fraser_syndrome_1,219000]
chr4	107236757	107236803	multi	46	1	4	6.16	0.078	chr4:107236757-107236803		AIMP1, TBCK		616899_[TBCK_(provisional)_Hypotonia,infantile,with_psychomotor_retardation_and_characteristic_facies_3,616900],603605_[AIMP1_(provisional)_Leukodystrophy,hypomyelinating,3,260600]
chr4	146575136	146575305	multi	169	1	3	4.82	0.039	chr4:146575136-146575305		MMAA		607481_[MMAA_(provisional)_Methylmalonic_aciduria,vitamin_B12-responsive,251100]
chr4	186990299	186990412	multi	113	1	3	3.69	0.033	chr4:186990299-186990412		TLR3		603029_[TLR3_(provisional)_Herpes_simplex_encephalitis,susceptibility_to,2_613002|HIV1_infection,resistance_to,609423]
chr5	52404342	52405335	multi	993	2	3,4	2.62,5.11	0.039,0.078	chr5:52404342-52404483,chr5:52405071-52405335		MOCS2		603708_[MOCS2_(provisional)_Molybdenum_cofactor_deficiency_B,252160]
chr5	74012402	74012508	multi	106	1	3	3.7	0.020	chr5:74012402-74012508		HEXB	HEXB	606873_[HEXB_(confirmed)_Sandhoff_disease,infantile,juvenile,and_adult_forms,268800]
chr5	88026018	88026061	multi	43	1	3	4.07	0.020	chr5:88026018-88026061		MEF2C	MEF2C	600662_[MEF2C_(confirmed)_Mental_retardation,stereotypic_movements,epilepsy,and/or_cerebral_malformations,613443|Chromosome_5q14.3_deletion_syndrome,613443]
chr5	90098546	90098709	multi	163	1	3	3.53	0.013	chr5:90098546-90098709		ADGRV1	ADGRV1	602851_[GPR98_(confirmed)_Febrile_seizures,familial,4,604352|Usher_syndrome,type_2C,605472|Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	132202309	132202737	multi	428	2	3,3	2,3.74	0.039,0.033	chr5:132202309-132202389,chr5:132202551-132202737		GDF9, UQCRQ		612080_[UQCRQ_(provisional)_Mitochondrial_complex_III_deficiency,nuclear_type_4,615159]
chr5	146460612	146460709	multi	97	1	3	4.5	0.013	chr5:146460612-146460709		PPP2R2B		604325_[PPP2R2B_(provisional)_Spinocerebellar_ataxia_12,604326]
chr6	32805304	32805438	multi	134	1	3	3.86	0.033	chr6:32805304-32805438		TAP2		170261_[TAP2_(confirmed)_Bare_lymphocyte_syndrome,type_I,due_to_TAP2_deficiency,604571|Wegener-like_granulomatosis]
chr6	32819876	32820289	multi	413	2	3,3	4.2,4.07	0.026,0.026	chr6:32819876-32820026,chr6:32820155-32820289		PSMB9, TAP1		170260_[TAP1_(confirmed)_Bare_lymphocyte_syndrome,type_I,604571]
chr6	52925724	52925854	multi	130	1	3	3.57	0.020	chr6:52925724-52925854		ICK		612325_[ICK_(provisional)_Endocrine-cerebroosteodysplasia,612651]
chr6	88258299	88258374	multi	75	1	3	3.72	0.013	chr6:88258299-88258374		RARS2		611524_[RARS2_(confirmed)_Pontocerebellar_hypoplasia,type_6,611523]
chr7	73474460	73474841	multi	381	2	1,1	-3,-4.21	0.020,0.078	chr7:73474460-73474524,chr7:73474696-73474841		ELN, ELN-AS1	ELN	608512_[NCF1_(provisional)_Chronic_granulomatous_disease_due_to_deficiency_of_NCF-1,233700],130160_[ELN_(confirmed)_Supravalvar_aortic_stenosis,185500|Cutis_laxa,autosomal_dominant,123700]
chr7	127983720	127983972	multi	252	1	3	3.84	0.105	chr7:127983720-127983972		RBM28		612074_[RBM28_(confirmed)_Alopecia,neurologic_defects,and_endocrinopathy_syndrome,612079]
chr7	128480592	128481034	multi	442	2	1,1	-3.14,-4.47	0.013,0.020	chr7:128480592-128480738,chr7:128480878-128481034	yes	FLNC		102565_[FLNC_(confirmed)_Myopathy,myofibrillar,5,609524|Myopathy,distal,4,614065|Cardiomyopathy,familial_hypertrophic,26|Cardiomyopathy,familial_restrictive_5,617047]
chr7	142986671	142986759	multi	88	1	3	3.77	0.046	chr7:142986671-142986759		CASP2		
chr8	43048890	43048996	multi	106	1	3	4.74	0.026	chr8:43048890-43048996		HGSNAT		610453_[HGSNAT_(confirmed)_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930|Retinitis_pigmentosa_73,616544]
chr8	48869905	48870001	multi	96	1	3	3.72	0.013	chr8:48869905-48870001		PRKDC		600899_[PRKDC_(confirmed)_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	100830669	100831126	multi	457	2	3,3	4.54,2.89	0.020,0.020	chr8:100830669-100830772,chr8:100830931-100831126		VPS13B	VPS13B	607817_[VPS13B_(confirmed)_Cohen_syndrome,216550]
chr8	100871522	100871718	multi	196	1	3	4.11	0.039	chr8:100871522-100871718		VPS13B	VPS13B	607817_[VPS13B_(confirmed)_Cohen_syndrome,216550]
chr8	140744212	140744455	multi	243	1	3	5.97	0.072	chr8:140744212-140744455		TRAPPC9		611966_[TRAPPC9_(provisional)_Mental_retardation,autosomal_recessive_13,613192]
chr9	470284	470692	multi	408	2	5,3	10,4.66	0.052,0.039	chr9:470284-470384,chr9:470546-470692		KANK1	KANK1	607704_[KANK1_(confirmed)_Cerebral_palsy,spastic_quadriplegic,2,612900]
chr9	6588391	6588452	multi	61	1	3	3.73	0.026	chr9:6588391-6588452		GLDC		238300_[GLDC_(confirmed)_Glycine_encephalopathy,605899]
chr9	34647076	34647574	multi	498	2	3,3	4,2.25	0.059,0.020	chr9:34647076-34647265,chr9:34647479-34647574		GALT		606999_[GALT_(confirmed)_Galactosemia,230400]
chr9	123744112	123744227	multi	115	1	3	4.6	0.007	chr9:123744112-123744227		C5		120900_[C5_(confirmed)_C5_deficiency,609536|Eculizumab,poor_response_to,615749]
chr9	124062324	124064455	multi	2131	2	1,1	-3.51,-2.62	0.046,0.033	chr9:124062324-124062414,chr9:124064231-124064455		GSN		137350_[GSN_(provisional)_Amyloidosis,Finnish_type,105120]
chr9	136433715	136433890	multi	175	1	1	-3.75	0.046	chr9:136433715-136433890		ADAMTSL2		612277_[ADAMTSL2_(provisional)_Geleophysic_dysplasia_1,231050]
chr10	43615519	43615661	multi	142	1	1	-3.55	0.059	chr10:43615519-43615661		RET	RET	164761_[RET_(confirmed)_Multiple_endocrine_neoplasia_IIA,171400|Medullary_thyroid_carcinoma,155240|Multiple_endocrine_neoplasia_IIB,162300|Central_hypoventilation_syndrome,congenital,209880|Pheochromocytoma,171300|Hirschsprung_disease,susceptibility_to,1,142623]
chr10	64575611	64576136	multi	525	1	3	3.84	0.020	chr10:64575611-64576136		EGR2		129010_[EGR2_(provisional)_Neuropathy,congenital_hypomyelinating,1,605253|Charcot-Marie-Tooth_disease,type_1D,607678|Dejerine-Sottas_disease,145900]
chr10	76074415	76074513	multi	98	1	3	4.01	0.052	chr10:76074415-76074513		ADK		102750_[ADK_(confirmed)_Hypermethioninemia_due_to_adenosine_kinase_deficiency,614300]
chr10	88466278	88469817	multi	3539	2	1,1	-3.59,-2.78	0.026,0.033	chr10:88466278-88466486,chr10:88469652-88469817		LDB3		605906_[LDB3_(confirmed)_Myopathy,myofibrillar,4,609452|Cardiomyopathy,dilated,1C,with_or_without_LVNC,601493|Cardiomyopathy,hypertrophic,24,601493|Left_ventricular_noncompaction_3,601493]
chr10	97515399	97515533	multi	134	1	3	3.83	0.052	chr10:97515399-97515533		ENTPD1, ENTPD1-AS1		601752_[ENTPD1_(provisional)_Spastic_paraplegia_64,autosomal_recessive,615683]
chr11	1780736	1780879	multi	143	1	1	-3.62	0.118	chr11:1780736-1780879		CTSD		116840_[CTSD_(confirmed)_Ceroid_lipofuscinosis,neuronal,10,610127]
chr11	44296888	44297218	multi	330	1	1	-3.67	0.013	chr11:44296888-44297218		ALX4	ALX4	605420_[ALX4_(provisional)_Parietal_foramina_2,609597|Frontonasal_dysplasia_2,613451|Craniosynostosis_5,susceptibility_to,615529]
chr11	47236483	47238033	multi	1550	2	3,3	3.9,3.78	0.046,0.052	chr11:47236483-47236824,chr11:47237877-47238033		DDB2		600811_[DDB2_(provisional)_Xeroderma_pigmentosum,group_E,DDB-negative_subtype,278740]
chr11	61160693	61160814	multi	121	1	3	3.73	0.013	chr11:61160693-61160814		TMEM216		613277_[TMEM216_(confirmed)_Joubert_syndrome_2,608091|Meckel_syndrome_2,603194]
chr11	65487506	65487645	multi	139	1	3	3.6	0.039	chr11:65487506-65487645		RNASEH2C		610330_[RNASEH2C_(provisional)_Aicardi-Goutieres_syndrome_3,610329]
chr11	66278109	66278187	multi	78	1	4	5.69	0.052	chr11:66278109-66278187		BBS1		209901_[BBS1_(confirmed)_Bardet-Biedl_syndrome_1,209900]
chr11	77850530	86749238	multi	8898708	2	4,3	8.48,2.09	0.065,0.046	chr11:77850530-77850709,chr11:86748876-86749238	yes	ALG8, ANKRD42, ARL6IP1P3, BCAS2P1, CCDC81, CCDC83, CCDC89, CCDC90B, COPS8P3, CREBZF, CYCSP28, DDIAS, DLG2, EED, FAM181B, FNTAP1, FZD4, GAB2, HIKESHI, HNRNPA1P72, HNRNPCP6, HNRNPCP8, KCTD21, KCTD21-AS1, LDHAL6DP, ME3, MIR4300, MIR5579, MIR708, NARS2, OR7E13P, OR7E2P, PCF11, PICALM, PRCP, PRSS23, PTP4A1P6, RAB30, RAB30-AS1, RN7SL225P, RNU6-1292P, RNU6-311P, RNU6-544P, RNU6-560P, SETP17, SLC25A1P1, SNORA70E, SNORD112, SYTL2, TENM4, TMEM126A, TMEM126B, TMEM135, USP35	FZD4	608103_[ALG8_(provisional)_Congenital_disorder_of_glycosylation,type_Ih,608104],612803_[NARS2_(provisional)_Combined_oxidative_phosphorylation_deficiency_24,616239],610084_[TENM4_(provisional)_Essential_tremor,hereditary,5,616736],610084_[ODZ4_(provisional)_Essential_tremor,hereditary,5,616736],615533_[TMEM126B_(provisional)_Mitochondrial_complex_I_deficiency,252010],612988_[TMEM126A_(provisional)_Optic_atrophy_7,612989],603025_[PICALM_(provisional)_Leukemia,acute_myeloid,somatic,601626],605984_[EED_(provisional)_Cohen-Gibson_syndrome,617561],604579_[FZD4_(confirmed)_Exudative_vitreoretinopathy_1,133780|Retinopathy_of_prematurity,133780]
chr11	108005859	108005979	multi	120	1	3	3.63	0.013	chr11:108005859-108005979		ACAT1		607809_[ACAT1_(confirmed)_Alpha-methylacetoacetic_aciduria,203750]
chr11	111741488	111742014	multi	526	1	3	5.12	0.039	chr11:111741488-111742014		ALG9		606941_[ALG9_(confirmed)_Congenital_disorder_of_glycosylation,type_Il,608776|Gillessen-Kaesbach-Nishimura_syndrome,263210]
chr11	111742065	111742315	multi	250	1	1	-3.53	0.033	chr11:111742065-111742315		ALG9		606941_[ALG9_(confirmed)_Congenital_disorder_of_glycosylation,type_Il,608776|Gillessen-Kaesbach-Nishimura_syndrome,263210]
chr12	6442225	6442323	multi	98	1	3	3.76	0.026	chr12:6442225-6442323		TNFRSF1A		191190_[TNFRSF1A_(confirmed)_Periodic_fever,familial,142680|Multiple_sclerosis,susceptibility_to,5,614810]
chr12	7341749	7342137	multi	388	1	3	3.82	0.039	chr12:7341749-7342137		PEX5		600414_[PEX5_(confirmed)_Peroxisome_biogenesis_disorder_2A_(Zellweger),214110|Peroxisome_biogenesis_disorder_2B,202370|Rhizomelic_chondrodysplasia_punctata,type_5,616716]
chr12	32906842	32907029	multi	187	1	3	3.79	0.013	chr12:32906842-32907029		YARS2		610957_[YARS2_(provisional)_Myopathy,lactic_acidosis,and_sideroblastic_anemia_2,613561]
chr12	44152737	44152829	multi	92	1	4	7.78	0.052	chr12:44152737-44152829		IRAK4		606883_[IRAK4_(provisional)_IRAK4_deficiency,607676|Invasive_pneumococcal_disease,recurrent_isolated,1,610799]
chr12	51019749	51019840	multi	91	1	3	4.87	0.039	chr12:51019749-51019840		DIP2B		611379_[DIP2B_(provisional)_Mental_retardation,FRA12A_type,136630]
chr12	58176518	58176651	multi	133	1	3	6.95	0.092	chr12:58176518-58176651		TSFM		604723_[TSFM_(confirmed)_Combined_oxidative_phosphorylation_deficiency_3,610505]
chr12	65138579	65138697	multi	118	1	3	3.86	0.020	chr12:65138579-65138697		GNS		607664_[GNS_(provisional)_Mucopolysaccharidosis_type_IIID,252940]
chr12	102151340	102151445	multi	105	1	3	3.8	0.046	chr12:102151340-102151445		GNPTAB		607840_[GNPTAB_(confirmed)_Mucolipidosis_III_alpha/beta,252600|Mucolipidosis_II_alpha/beta,252500]
chr13	23894766	23894909	multi	143	1	3	3.54	0.013	chr13:23894766-23894909		SGCG		608896_[SGCG_(confirmed)_Muscular_dystrophy,limb-girdle,type_2C,253700]
chr14	35182870	35183033	multi	163	1	3	5.71	0.020	chr14:35182870-35183033		CFL2		601443_[CFL2_(confirmed)_Nemaline_myopathy_7,autosomal_recessive,610687]
chr14	55312476	55312580	multi	104	1	3	4.45	0.020	chr14:55312476-55312580		GCH1		600225_[GCH1_(provisional)_Dystonia,DOPA-responsive,with_or_without_hyperphenylalaninemia,128230|Hyperphenylalaninemia,BH4-deficient,B,233910]
chr14	64375806	64375955	multi	149	1	3	3.67	0.020	chr14:64375806-64375955		SYNE2		608442_[SYNE2_(provisional)_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999]
chr14	77745062	77745222	multi	160	1	1	-4.28	0.026	chr14:77745062-77745222		POMT2		607439_[POMT2_(confirmed)_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,2,613150|Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,2,613156|Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,2,613158]
chr14	77915626	77915710	multi	84	1	3	4.53	0.026	chr14:77915626-77915710		VIPAS39		613401_[VIPAS39_(provisional)_Arthrogryposis,renal_dysfunction,and_cholestasis_2,613404]
chr15	34610752	34629055	multi	18303	2	3,3	4.91,3.05	0.078,0.026	chr15:34610752-34611031,chr15:34628601-34629055		SLC12A6		604878_[SLC12A6_(confirmed)_Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy,218000]
chr15	49089848	49089937	multi	89	1	3	4.37	0.039	chr15:49089848-49089937		CEP152		613529_[CEP152_(provisional)_Microcephaly_9,primary,autosomal_recessive,614852|Seckel_syndrome_5,613823]
chr15	51233853	51233982	multi	129	1	3	3.56	0.007	chr15:51233853-51233982		AP4E1		607244_[AP4E1_(provisional)_Spastic_paraplegia_51,autosomal_recessive,613744|Stuttering,familial_persistent,1,184450]
chr15	74495334	74495566	multi	232	1	3	3.66	0.033	chr15:74495334-74495566		STRA6		610745_[STRA6_(provisional)_Microphthalmia,syndromic_9,601186|Microphthalmia,isolated,with_coloboma_8,601186]
chr15	91565374	91565843	multi	469	1	3	4.93	0.039	chr15:91565374-91565843		VPS33B		608552_[VPS33B_(provisional)_Arthrogryposis,renal_dysfunction,and_cholestasis_1,208085]
chr16	5129739	5131067	multi	1328	2	1,1	-2.91,-3.86	0.020,0.046	chr16:5129739-5129818,chr16:5130937-5131067		ALG1		605907_[ALG1_(provisional)_Congenital_disorder_of_glycosylation,type_Ik,608540]
chr16	28947823	28947931	multi	108	1	3	5.18	0.033	chr16:28947823-28947931		CD19		107265_[CD19_(provisional)_Immunodeficiency,common_variable,3,613493]
chr16	28949984	28950309	multi	325	2	1,1	-2.21,-3.78	0.026,0.013	chr16:28949984-28950099,chr16:28950183-28950309		CD19		107265_[CD19_(provisional)_Immunodeficiency,common_variable,3,613493]
chr16	30198693	30198832	multi	139	1	4	4.33	0.026	chr16:30198693-30198832	yes	CORO1A		605000_[CORO1A_(provisional)_Immunodeficiency_8,615401]
chr16	31199636	31199688	multi	52	1	3	3.98	0.039	chr16:31199636-31199688		FUS		137070_[FUS_(confirmed)_Amyotrophic_lateral_sclerosis_6,with_or_without_frontotemporal_dementia,608030|Essential_tremor,hereditary,4,614782]
chr16	66551029	66551128	multi	99	1	4	6.77	0.039	chr16:66551029-66551128		TK2		188250_[TK2_(confirmed)_Mitochondrial_DNA_depletion_syndrome_2_(myopathic_type),609560|Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_3,617069]
chr17	38804015	38804113	multi	98	1	3	4.51	0.033	chr17:38804015-38804113		KRT222, SMARCE1		603111_[SMARCE1_(provisional)_Meningioma,familial,susceptibility_to,607174|Coffin-Siris_syndrome_5,616938]
chr17	40370731	40370906	multi	175	1	1	-3.91	0.046	chr17:40370731-40370906		STAT5B		604260_[STAT5B_(provisional)_Leukemia,acute_promyelocytic,somatic,102578|Growth_hormone_insensitivity_with_immunodeficiency,245590]
chr17	40371720	40371870	multi	150	1	1	-3.55	0.065	chr17:40371720-40371870		STAT5B		604260_[STAT5B_(provisional)_Leukemia,acute_promyelocytic,somatic,102578|Growth_hormone_insensitivity_with_immunodeficiency,245590]
chr17	40695036	42083289	multi	1388253	2	1,1	-2.49,-3.52	0.007,0.124	chr17:40695036-40696476,chr17:42082995-42083289	yes	AARSD1, AOC2, AOC3, AOC4P, ARL4D, ATP5MGP7, BECN1, BRCA1, CCR10, CD300LG, CFAP97D1, CNTD1, CNTNAP1, COA3, COASY, DHX8, DUSP3, ETV4, EZH1, FAM215A, G6PC, HMGB3P27, HMGN2P15, HSD17B1, HSD17B1P1, IFI35, LINC00671, LINC00854, LINC00910, MEOX1, MIR2117, MLX, MPP2, MPP3, NAGLU, NAGS, NBR1, NBR2, PLEKHH3, PPY, PSMC3IP, PSME3, PTGES3L, PTGES3L-AARSD1, PYY, RAMP2, RAMP2-AS1, RETREG3, RND2, RNU6-1137P, RNU6-287P, RNU6-406P, RNU6-470P, RNU6-971P, RNY4P2, RPL21P4, RPL27, RUNDC1, SNORA40, SOST, TMEM106A, TUBG1, TUBG2, VAT1, VPS25, WNK4	CNTNAP1,SOST	609701_[NAGLU_(confirmed)_Mucopolysaccharidosis_type_IIIB_(Sanfilippo_B),252920|Charcot-Marie-Tooth_disease,axonal,type_2V,616491],609855_[COASY_(provisional)_Neurodegeneration_with_brain_iron_accumulation_6,615643],608665_[PSMC3IP_(confirmed)_Ovarian_dysgenesis_3,614324],191135_[TUBG1_(provisional)_Cortical_dysplasia,complex,with_other_brain_malformations_4,615412],602346_[CNTNAP1_(provisional)_Lethal_congenital_contracture_syndrome_7,616286],601844_[WNK4_(confirmed)_Pseudohypoaldosteronism,type_IIB,614491],613742_[G6PC_(confirmed)_Glycogen_storage_disease_Ia,232200],607526_[RPL27_(provisional)_Diamond-Blackfan_anemia_16,617408],113705_[BRCA1_(confirmed)_Breast-ovarian_cancer,familial,1,604370|Pancreatic_cancer,susceptibility_to,4,614320],600147_[MEOX1_(confirmed)_Klippel-Feil_syndrome_2,214300],605740_[SOST_(confirmed)_Sclerosteosis_1,269500|Van_Buchem_disease,239100|Craniodiaphyseal_dysplasia,autosomal_dominant,122860],608300_[NAGS_(confirmed)_N-acetylglutamate_synthase_deficiency,237310]
chr17	57078949	57079085	multi	136	1	3	3.95	0.065	chr17:57078949-57079085		TRIM37		605073_[TRIM37_(confirmed)_Mulibrey_nanism,253250]
chr17	62009545	62009714	multi	169	1	3	4.22	0.013	chr17:62009545-62009714		CD79B		147245_[CD79B_(provisional)_Agammaglobulinemia_6,612692]
chr17	62479026	62479126	multi	100	1	4	4.09	0.137	chr17:62479026-62479126		POLG2		604983_[POLG2_(provisional)_Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_dominant_4,610131]
chr17	62488774	62488899	multi	125	1	6	10	0.098	chr17:62488774-62488899		POLG2		604983_[POLG2_(provisional)_Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_dominant_4,610131]
chr18	3447598	3447805	multi	207	1	3	5.85	0.033	chr18:3447598-3447805		TGIF1	TGIF1	602630_[TGIF1_(confirmed)_Holoprosencephaly_4,142946]
chr18	3453762	3453864	multi	102	1	3	4.2	0.039	chr18:3453762-3453864		TGIF1	TGIF1	602630_[TGIF1_(confirmed)_Holoprosencephaly_4,142946]
chr18	9119314	9119598	multi	284	2	3,3	3.79,2.69	0.059,0.052	chr18:9119314-9119396,chr18:9119462-9119598		NDUFV2		600532_[NDUFV2_(confirmed)_Mitochondrial_complex_I_deficiency,252010]
chr18	21119309	21119444	multi	135	1	3	3.8	0.020	chr18:21119309-21119444		NPC1		607623_[NPC1_(confirmed)_Niemann-Pick_disease,type_C1,257220|Niemann-Pick_disease,type_D,257220]
chr18	21120402	21121182	multi	780	2	3,3	6.86,3.61	0.020,0.013	chr18:21120402-21120511,chr18:21121022-21121182		NPC1		607623_[NPC1_(confirmed)_Niemann-Pick_disease,type_C1,257220|Niemann-Pick_disease,type_D,257220]
chr18	21393011	21393077	multi	66	1	3	4.04	0.020	chr18:21393011-21393077		LAMA3		600805_[LAMA3_(provisional)_Epidermolysis_bullosa,junctional,Herlitz_type,226700|Epidermolysis_bullosa,generalized_atrophic_benign,226650|Laryngoonychocutaneous_syndrome,245660]
chr18	21426251	21426482	multi	231	1	3	3.71	0.085	chr18:21426251-21426482		LAMA3		600805_[LAMA3_(provisional)_Epidermolysis_bullosa,junctional,Herlitz_type,226700|Epidermolysis_bullosa,generalized_atrophic_benign,226650|Laryngoonychocutaneous_syndrome,245660]
chr18	33722234	33722320	multi	86	1	3	3.62	0.013	chr18:33722234-33722320		ELP2		616054_[ELP2_(provisional)_Mental_retardation,autosomal_recessive_58,617270]
chr18	53255259	53255870	multi	611	1	3	4.43	0.033	chr18:53255259-53255870		TCF4	TCF4	602272_[TCF4_(confirmed)_Pitt-Hopkins_syndrome,610954|Corneal_dystrophy,Fuchs_endothelial,3,613267]
chr19	12776156	12776629	multi	473	2	3,3	4.02,3.94	0.033,0.026	chr19:12776156-12776349,chr19:12776507-12776629		MAN2B1		609458_[MAN2B1_(confirmed)_Mannosidosis,alpha-,types_I_and_II,248500]
chr19	13008107	13008252	multi	145	1	1	-3.73	0.020	chr19:13008107-13008252		GCDH		608801_[GCDH_(confirmed)_Glutaricaciduria,type_I,231670]
chr19	14029933	14030025	multi	92	1	1	-3.88	0.196	chr19:14029933-14030025		CC2D1A		610055_[CC2D1A_(provisional)_Mental_retardation,autosomal_recessive_3,608443]
chr19	15289624	15289762	multi	138	1	1	-3.58	0.007	chr19:15289624-15289762		NOTCH3	NOTCH3	600276_[NOTCH3_(confirmed)_Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310|Myofibromatosis,infantile_2,615293|Lateral_meningocele_syndrome,130720]
chr19	15298682	15298815	multi	133	1	3	3.55	0.065	chr19:15298682-15298815		NOTCH3	NOTCH3	600276_[NOTCH3_(confirmed)_Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310|Myofibromatosis,infantile_2,615293|Lateral_meningocele_syndrome,130720]
chr19	19307762	19307865	multi	103	1	3	3.99	0.052	chr19:19307762-19307865		RFXANK		603200_[RFXANK_(provisional)_MHC_class_II_deficiency,complementation_group_B,209920]
chr19	36591640	36592686	multi	1046	3	1,1,1	-2.03,-4.18,-2.4	0.020,0.020,0.039	chr19:36591640-36591787,chr19:36592106-36592229,chr19:36592556-36592686		WDR62		613583_[WDR62_(confirmed)_Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317]
chr19	38932979	38934282	multi	1303	2	1,1	-3.53,-3.23	0.046,0.020	chr19:38932979-38933103,chr19:38934188-38934282		RYR1		180901_[RYR1_(confirmed)_Malignant_hyperthermia_susceptibility_1,145600|Central_core_disease,117000|Minicore_myopathy_with_external_ophthalmoplegia,255320|Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000|King-Denborough_syndrome,145600]
chr19	39015962	39016152	multi	190	1	1	-3.4	0.026	chr19:39015962-39016152		RYR1		180901_[RYR1_(confirmed)_Malignant_hyperthermia_susceptibility_1,145600|Central_core_disease,117000|Minicore_myopathy_with_external_ophthalmoplegia,255320|Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000|King-Denborough_syndrome,145600]
chr19	41893409	41893518	multi	109	1	1	-3.67	0.033	chr19:41893409-41893518		BCKDHA, EXOSC5		608348_[BCKDHA_(confirmed)_Maple_syrup_urine_disease,type_Ia,248600]
chr19	41903684	41903850	multi	166	1	4	5.75	0.059	chr19:41903684-41903850		BCKDHA		608348_[BCKDHA_(confirmed)_Maple_syrup_urine_disease,type_Ia,248600]
chr19	44030343	44030821	multi	478	2	3,3	6.17,3.29	0.026,0.052	chr19:44030343-44030511,chr19:44030657-44030821		ETHE1, ZNF575		608451_[ETHE1_(provisional)_Ethylmalonic_encephalopathy,602473]
chr19	45926518	45926830	multi	312	1	3	3.95	0.092	chr19:45926518-45926830		ERCC1		126380_[ERCC1_(confirmed)_Cerebrooculofacioskeletal_syndrome_4,610758]
chr19	50432573	50432998	multi	425	1	1	-3.52	0.033	chr19:50432573-50432998		ATF5, IL4I1, NUP62		605815_[NUP62_(confirmed)_Striatonigral_degeneration,infantile,271930]
chr19	51869514	51869682	multi	168	1	5	7.07	0.065	chr19:51869514-51869682		ETFB		130410_[ETFB_(confirmed)_Glutaric_acidemia_IIB,231680]
chr19	54401684	54401892	multi	208	1	1	-3.59	0.059	chr19:54401684-54401892		PRKCG		176980_[PRKCG_(confirmed)_Spinocerebellar_ataxia_14,605361]
chr20	31381332	31381411	multi	79	1	3	4.27	0.007	chr20:31381332-31381411		DNMT3B	DNMT3B	602900_[DNMT3B_(confirmed)_Immunodeficiency-centromeric_instability-facial_anomalies_syndrome_1,242860]
chr20	33524556	33524653	multi	97	1	3	3.71	0.013	chr20:33524556-33524653		GSS		601002_[GSS_(provisional)_Hemolytic_anemia_due_to_glutathione_synthetase_deficiency,231900|Glutathione_synthetase_deficiency,266130]
chr20	35555575	35559288	multi	3713	2	3,3	4.24,4.02	0.033,0.046	chr20:35555575-35555665,chr20:35559153-35559288		SAMHD1		606754_[SAMHD1_(provisional)_Aicardi-Goutieres_syndrome_5,612952|Chilblain_lupus_2,614415]
chr21	46308598	46308820	multi	222	1	1	-3.54	0.026	chr21:46308598-46308820		ITGB2		600065_[ITGB2_(confirmed)_Leukocyte_adhesion_deficiency,116920]
chr21	46898231	46898277	multi	46	1	4	8.4	0.052	chr21:46898231-46898277		COL18A1		120328_[COL18A1_(confirmed)_Knobloch_syndrome,type_1,267750]
chr22	38577661	38577846	multi	185	2	4,3	6.73,3.59	0.072,0.078	chr22:38577661-38577771,chr22:38577781-38577846		PLA2G6		603604_[PLA2G6_(confirmed)_Infantile_neuroaxonal_dystrophy_1,256600|Neurodegeneration_with_brain_iron_accumulation_2B,610217|Parkinson_disease_14,autosomal_recessive,612953]
chr22	41256672	41256807	multi	135	1	4	6.03	0.092	chr22:41256672-41256807		DNAJB7, XPNPEP3		613553_[XPNPEP3_(confirmed)_Nephronophthisis-like_nephropathy_1,613159]
chr22	42524776	42526893	multi	2117	2	1,1	-4.47,-2.41	0.092,0.144	chr22:42524776-42524956,chr22:42526604-42526893	yes	CYP2D6, NDUFA6-AS1	CYP2D6	124030_[CYP2D6_(confirmed)_Debrisoquine_sensitivity,608902|Codeine_sensitivity,608902]
chrX	10124975	10153226	multi	28251	2	3,3	3.6,3.05	0.026,0.013	chrX:10124975-10125150,chrX:10153052-10153226		CLCN4		302910_[CLCN4_(provisional)_Mental_retardation,X-linked_49/15,300114]
chrX	12719983	12720139	multi	156	1	3	4.18	0.033	chrX:12719983-12720139		FRMPD4		300838_[FRMPD4_(provisional)_Mental_retardation,X-linked_104,300983]
chrX	19369368	19371301	multi	1933	2	3,3	4.44,2.29	0.033,0.052	chrX:19369368-19369535,chrX:19371190-19371301		PDHA1	PDHA1	300502_[PDHA1_(confirmed)_Pyruvate_dehydrogenase_E1-alpha_deficiency,312170]
chrX	24075740	24078309	multi	2569	2	3,3	3.89,2.57	0.013,0.033	chrX:24075740-24075881,chrX:24078195-24078309		EIF2S3		300161_[EIF2S3_(provisional)_MEHMO_syndrome,300148]
chrX	44894166	44894240	multi	74	1	3	3.76	0.033	chrX:44894166-44894240		KDM6A	KDM6A	300128_[KDM6A_(provisional)_Kabuki_syndrome_2,300867]
chrX	47040604	47041055	multi	451	2	1,1	-2.64,-3.92	0.026,0.020	chrX:47040604-47040810,chrX:47040896-47041055		RBM10		300080_[RBM10_(provisional)_TARP_syndrome,311900]
chrX	49086672	49087081	multi	409	2	3,3	3.74,2.63	0.013,0.026	chrX:49086672-49086844,chrX:49086919-49087081		CACNA1F		300110_[CACNA1F_(confirmed)_Night_blindness,congenital_stationary_(incomplete),2A,X-linked,300071|Cone-rod_dystrophy,X-linked,3,300476|Aland_Island_eye_disease,300600]
chrX	53250011	53250108	multi	97	1	3	4.35	0.118	chrX:53250011-53250108		KDM5C	KDM5C	314690_[KDM5C_(confirmed)_Mental_retardation,X-linked,syndromic,Claes-Jensen_type,300534]
chrX	53613440	53613541	multi	101	1	3	3.77	0.026	chrX:53613440-53613541		HUWE1	HUWE1	300697_[HUWE1_(provisional)_Mental_retardation,X-linked_syndromic,Turner_type,300706]
chrX	54497006	54497203	multi	197	1	1	-3.58	0.026	chrX:54497006-54497203		FGD1	FGD1	300546_[FGD1_(confirmed)_Aarskog-Scott_syndrome,305400|Mental_retardation,X-linked_syndromic_16,305400]
chrX	67417018	67417116	multi	98	1	3	5.38	0.033	chrX:67417018-67417116		OPHN1	OPHN1	300127_[OPHN1_(provisional)_Mental_retardation,X-linked,with_cerebellar_hypoplasia_and_distinctive_facial_appearance,300486]
chrX	70360475	70361824	multi	1349	3	1,1,1	-2.39,-4.75,-3.25	0.033,0.033,0.020	chrX:70360475-70360717,chrX:70361070-70361230,chrX:70361723-70361824		MED12		300188_[MED12_(confirmed)_Opitz-Kaveggia_syndrome,305450|Lujan-Fryns_syndrome,309520|Ohdo_syndrome,X-linked,300895]
chrX	77166184	77166342	multi	158	1	3	4.97	0.039	chrX:77166184-77166342		ATP7A	ATP7A	300011_[ATP7A_(confirmed)_Menkes_disease,309400|Occipital_horn_syndrome,304150|Spinal_muscular_atrophy,distal,X-linked_3,300489]
chrX	99661439	99665281	multi	3842	1	1	-3.99	0.007	chrX:99661439-99665281		PCDH19	PCDH19	300460_[PCDH19_(confirmed)_Epileptic_encephalopathy,early_infantile,9,300088]
chrX	128947643	128947711	multi	68	1	3	6.01	0.007	chrX:128947643-128947711		ZDHHC9	ZDHHC9	300646_[ZDHHC9_(confirmed)_Mental_retardation,X-linked_syndromic,Raymond_type,300799]
chrX	133632410	133632476	multi	66	1	3	4.57	0.020	chrX:133632410-133632476		HPRT1	HPRT1	308000_[HPRT1_(confirmed)_Lesch-Nyhan_syndrome,300322|HPRT-related_gout,300323]
chrX	135758773	135758886	multi	113	1	3	4.54	0.020	chrX:135758773-135758886		ARHGEF6	ARHGEF6	300267_[ARHGEF6_(confirmed)_Mental_retardation,X-linked_46,300436]
chrX	135827372	135829761	multi	2389	2	3,4	2.97,8.82	0.039,0.033	chrX:135827372-135827516,chrX:135829657-135829761		ARHGEF6	ARHGEF6	300267_[ARHGEF6_(confirmed)_Mental_retardation,X-linked_46,300436]
chrX	139585142	139587235	multi	2093	1	1	-3.63	0.007	chrX:139585142-139587235		SOX3	SOX3	313430_[SOX3_(confirmed)_Mental_retardation,X-linked,with_isolated_growth_hormone_deficiency,300123|Panhypopituitarism,X-linked,312000]
